Skip to main content
HUAPONT LIFE SCIENCES CO., LTD. logo

HUAPONT LIFE SCIENCES CO., LTD. — Investor Relations & Filings

Ticker · 002004 ISIN · CNE000001JJ6 LEI · 3003009TGXJC0JJVTJ07 Shenzhen Stock Exchange Manufacturing
Filings indexed 2,461 across all filing types
Latest filing 2021-08-18 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 002004

About HUAPONT LIFE SCIENCES CO., LTD.

https://www.huapont.com.cn

HUAPONT LIFE SCIENCES CO., LTD. operates as a diversified entity specializing in the research, development, manufacturing, and distribution of pharmaceutical and chemical solutions. The company holds a prominent position in the dermatology sector, providing a comprehensive range of therapeutic products for various skin disorders. Its pharmaceutical operations extend to the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Beyond human health, the organization maintains a significant footprint in the agrochemical sector, focusing on the development and supply of crop protection products, including herbicides and pesticides. The company also integrates healthcare services into its business model, overseeing the operation of medical facilities and specialized clinics. Its strategic focus centers on technological advancement and the maintenance of a robust supply chain to support its global commercial activities.

Recent filings

Filing Released Lang Actions
华邦健康:资产减值准备计提及核销管理制度(2021年8月)
Governance Information Classification · 95% confidence The document is a detailed internal management system for asset impairment provision and write-off procedures of a company, including accounting standards, measurement methods, approval authorities, and related internal controls. It does not contain financial statements, earnings data, or regulatory disclosures typical of annual or interim reports. It is not an announcement or a brief summary but a comprehensive internal policy document. It does not fit categories like Annual Report (10-K), Interim Report (IR), Earnings Release (ER), or Audit Report (AR). It is also not a regulatory filing or announcement. The content is about internal management and governance of asset impairment accounting, which aligns best with Governance Information (CGR) as it details internal rules and procedures related to financial governance and asset management.
2021-08-18 Chinese
关于调整公司组织架构的公告
Board/Management Information Classification · 100% confidence The document is an announcement from Huabang Life Health Co., Ltd. regarding an adjustment to the company's organizational structure, specifically merging two departments. It includes a statement from the board and an updated organizational chart. There is no financial data, no mention of annual or quarterly reports, no voting results, no legal proceedings, or other report types. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management or organizational structure changes.
2021-08-18 Chinese
独立董事关于聘任高级管理人员的独立意见
Board/Management Information Classification · 100% confidence The document is an independent opinion from independent directors regarding the appointment of senior management personnel, including the general manager, board secretary, and financial director. It discusses the approval and qualifications of these appointments. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management. The document is short and focused solely on management appointments, with no financial data or other report content.
2021-08-18 Chinese
第八届监事会第一次会议决议公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the election of the chairman of the supervisory board (监事会主席) of the company 华邦生命健康股份有限公司. It details the meeting date, voting results, and includes the biography of the elected chairman. There is no financial data, no mention of financial results, no regulatory certifications, or report attachments. The content is about board/management changes, specifically the supervisory board leadership. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused on management changes, not a report or announcement of a report publication.
2021-08-18 Chinese
华邦健康:总经理工作细则(2021年8月)
Governance Information Classification · 95% confidence The document is titled as "华邦生命健康股份有限公司 总经理工作细则" which translates to "General Manager Work Rules" of the company. It details the roles, responsibilities, appointment, and operational procedures related to the company's general manager and other senior management personnel. The content is focused on internal management rules and governance practices rather than financial results, audit opinions, or shareholder meeting materials. There is no indication of financial data, earnings, voting results, or regulatory filings. The document aligns with governance practices and internal management rules. Therefore, the most appropriate classification is Governance Information (CGR). The document length (5311 characters) and detailed procedural content support this classification with high confidence.
2021-08-18 Chinese
华邦健康:信息披露管理制度(2021年8月)
Governance Information Classification · 95% confidence The document is titled as an "Information Disclosure Management System" for a company, detailing the rules, procedures, responsibilities, and standards for information disclosure. It extensively covers regulatory compliance, internal controls, reporting timelines, and obligations related to periodic reports (annual, semi-annual, quarterly), interim and temporary reports, and major event disclosures. It does not contain actual financial statements or financial performance data but rather outlines the governance and management framework for disclosures. This type of document is a governance or compliance manual related to information disclosure practices rather than a financial report or announcement. Therefore, it fits best under Governance Information (CGR).
2021-08-18 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.